Cannabinoid Antagonist in Obesity Treatment

Tessa van der Merwe

Abstract


CP-945.598 is an orally active selective antagonist of the cannabinoid CB-1 receptor that was being developed for weight loss, and prevention of weight regain in obese and overweight individuals.

Full Text: PDF


This journal is hosted by: OpenJournals Publishing. This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.5 South Africa License